The following video is part of our "Motley Fool Conversations" series, in which Motley Fool technology editor Andre w Tonner and consumer goods editor Austin Smith discuss their favorite stocks.
In today's edition, Andrew and Austin talk about one dividend stock they'd buy, and one they'd sell going into the New Year. As many people make resolutions to get in shape, eat healthier, and be nicer, they often forget that their portfolios could probably use a similar realignment. Don't overlook this company to buy, or fool yourself into thinking the one company to sell has a secretly bright future.
In fact, as we move out of the recession and everyone reflects on the unbelievably resilient impact dividends can have on a portfolio, The Motley Fool decided investors need a wide breadth of solid dividend selections. To meet this need we compiled a special FREE report: "Secure Your Future With 11 Rock-Solid Dividend Stocks." In it, you'll uncover 11 dividend stocks that let you sleep easy and retire rich, including the one we've suggested here. To check out the details about these stocks, click here, it won't cost a penny.
At the time thisarticle was published Austin Smith owns shares of Pfizer. Andrew Tonner own no shares of the companies listed above. The Motley Fool owns shares of Johnson & Johnson.Motley Fool newsletter serviceshave recommended buying shares of Johnson & Johnson and Pfizer, as well as creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter servicesfree for 30 days. We Fools may not all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.
Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.